BiotechTube
Home/ReGelTec/Mark Collins, CPA
MC

Mark Collins, CPA

CFO

ReGelTec

Therapeutic Areas

MusculoskeletalPain

ReGelTec Pipeline

DrugIndicationPhase
HYDRAFIL SystemChronic low back pain due to degenerative disc disease (DDD)Pivotal Trial (IDE)

Leadership Team at ReGelTec

PB
Peter Boyd, JD, MBA
CEO
DA
Dr. Anthony Lowman
CTO & Co-Founder
View full ReGelTec profile